Trial of Preemptive Pharmacogenetic Testing in Underserved Patients (TOPP UP): Study Framework and Baseline Characteristics of Randomized Controlled Trial Participants在弱势患者中进行的预防性药物基因组学检测试验(TOPP UP):随机对照试验的研究框架和参与者基线特征Clinical and Translational ScienceIF2.82026-02-230OAAI
The potential of AB-free kava in enabling tobacco cessation via management of abstinence-related stress and insomnia: study protocol for a randomized clinical trialBMC COMPLEMENTARY MEDICINE AND THERAPIESIF3.42024-12-210OAAI
One-Week Kava Dietary Supplementation Increases Both Urinary N- and O-Glucuronides of NNAL, a Lung Carcinogen Major Metabolite, among SmokersCHEMICAL RESEARCH IN TOXICOLOGYIF3.82024-07-130PRE
Potential of kava in reducing lung cancer risk and associated disparities: Mechanism-based biomarker discovery and analysisCANCER RESEARCHIF16.62024-03-220PRE
Feasibility of preemptive pharmacogenetic testing and improvement of medication treatment satisfaction among medically underserved patientsCTS-CLINICAL AND TRANSLATIONAL SCIENCEIF2.82023-12-031OA
Adipose Tissue Insulin Resistance Predicts the Severity of Liver Fibrosis in Patients With Type 2 Diabetes and NAFLDJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISMIF5.12022-11-1626OA
Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic ScreeningDIABETES CAREIF16.62021-01-13201OAAI